Experienced in Malignant Peripheral Nerve Sheath Tumor

Dr. Amit W. Panwalkar

Hematology Oncology | Hematology | Oncology
Sanford Medical Center Fargo
1000 Coney St W, 
Perham, MN 
Accepting New Patients
Experienced in Malignant Peripheral Nerve Sheath Tumor
Sanford Medical Center Fargo
1000 Coney St W, 
Perham, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amit Panwalkar is a Hematologist Oncology specialist and a Hematologist in Perham, Minnesota. Dr. Panwalkar is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Colorectal Cancer, Lynch Syndrome, Paget Disease of the Breast, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Panwalkar is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NE
Hospital Affiliations
Sanford Thief River Falls Medical Center
Sanford Medical Center Fargo
Sanford Wheaton Medical Center
Perham Health
Jamestown Regional Medical Center
Languages Spoken
English
Hindi
Marathi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

SANFORD MEDICAL CENTER FARGO
1000 Coney St W, Perham, MN 56573
Other Locations
SANFORD MEDICAL CENTER FARGO
801 Broadway N, Fargo, ND 58102
SANFORD MEDICAL CENTER FARGO
1220 Sheyenne St, West Fargo, ND 58078
SANFORD MEDICAL CENTER FARGO
1233 34th St Nw, Bemidji, MN 56601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Expansion Cohort Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients
Expansion Cohort Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients
Enrollment Status: Terminated
Publish Date: January 07, 2025
Intervention Type: Drug, Other
Study Drugs: Disulfiram, Gemcitabine
Study Phase: Phase 1
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial
Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 24, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 21, 2020
Similar Doctors
Experienced in Malignant Peripheral Nerve Sheath Tumor
Dr. Preston D. Steen
Oncology | Hematology
Experienced in Malignant Peripheral Nerve Sheath Tumor
Dr. Preston D. Steen
Oncology | Hematology
820 4th Street North, 
Fargo, ND 
 (59.9 miles away)
701-234-2397
Languages Spoken:
English
See accepted insurances

Preston Steen is an Oncologist and a Hematologist in Fargo, North Dakota. Dr. Steen is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His top areas of expertise are Colorectal Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Colonoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Panwalkar's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 38 Advanced Conditions
    View All 139 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile